TUESDAY, SEPTEMBER 19, 2017

Impax sells Daraprim rights to Turing Pharmaceuticals

According to a recent announcement, Turing Pharmaceuticals AG has purchased the United States rights of Impax Laboratories Inc.’s Daraprim brand for approximately $55 million. Read More »

Floridians warned of West Nile virus

Scientists from UF/IFAS Florida Medical Entomology Laboratory in Vero Beach have warned Florida residents to remain cautious of West Nile virus. Read More »

Crime scene compound may treat malaria

Detectives use a compound to spray crime scenes for trace amounts of blood, and in the future this compound may be used to kill the parasite that causes malaria. Read More »

Scientists seek to improve flu vaccine

Scientists from Johns Hopkins Bloomberg School of Public Health recently reported that they have created a method that would make the nasal spray flu vaccine more effective for people both under two years old and over 49 years old. Read More »

Cellular Biomedicine Group names chief scientific officer

Yihong Yao joins biomedicine firm from MedImmune/AstraZeneca Read More »

$40 million grant to improve HIV and TB response in Sudan

A $40 million grant will be used to improve the HIV and tuberculosis (TB) response in Sudan and to reach the most vulnerable population. Read More »

Mississippi officials confirm four new West Nile virus cases

Health officials from the Mississippi State Department of Health (MSDH) recently confirmed that there have been four new cases of the West Nile virus in the state, bringing the number of cases to seven for the year. Read More »

Epidemic bacterial disease mechanism discovered in 'flesh-eating' strep

Scientists for the first time were able to identify the mechanism behind epidemic levels of A streptococcus, also called the “flesh-eating” bacterium, in a recent study. This is the first time that researchers were able to do this. By studying heightened toxin production in the molecules, they determined that these molecular events are a major factor in large epidemics of the illness. Read More »

Pneumonia patients can benefit from steroid therapy

Recent research from McMaster University’s Michael G. DeGroote School of Medicine published online Monday in the Annals of Internal Medicine suggests that pneumonia patients have significant benefits from corticosteroid therapy. Read More »

iBio to gain U.S. patent for novel influenza therapeutic product

iBio Inc., a pioneer in plant-based biotechnology that creates and produces biopharmaceutical products, recently received notice that its U.S. patent for the company’s monoclonal antibody targeting influenza will be issued on Aug. 26, 2015. Read More »

Novavax releases positive results of phase 2 RSV F-protein vaccine clinical trial

Novavax recently announced the positive top-line data from the company’s phase 2 clinical trial of its respiratory syncytial virus (RSV) F-protein vaccine, which is specifically designed for older adults. Read More »

Back-to-school vaccines are for more than just students

The back-to-school season is a yearly reminder for parents to verify that their children have been vaccinated, but adults are also encouraged to use the back-to-school season to update their own immunizations. Read More »

BiolQ optimizes flu vaccines via secure technology platform

According to a recent announcement, BiolQ has developed a new secure technology platform that streamlines the flu vaccination programs for employers with any size of workforce. Read More »

Flu may be preventable without vaccines

Scientists recently found a way to provoke an immune response against the flu without using the virus or interferon, which is a strong infection fighter. Read More »

Research furthers development of test for oral and genital herpes

Scientists at the National Institutes of Health (NIH), Johns Hopkins and Harvard universities have discovered some new research that could advance creating a universally accurate diagnostic test for the human herpes simplex viruses (HSV). Read More »

Heart risk may increase with hepatitis C infections

New research from Johns Hopkins suggests that people with hepatitis C virus infections have an increased risk for heart trouble. Read More »

Florida reports record low number of babies born with HIV

Florida recently reported that the number of babies who are born with HIV has now dropped to a record-breaking low. Read More »

SIV evades vaccine antibodies in monkeys

Researchers at Yerkes National Primate Research Center as well as the Emory Vaccine Center recently stated that SIV is able to infect monkeys with the SIV vaccine because the virus can shrug off and evade the monkeys’ antibodies. Read More »

Health officials credit vaccinations with chickenpox decline in U.S.

CDC study shows hospitalizations down drastically, as well as outpatient visits. Read More »

Mark Feinberg named president and CEO of IAVI

Former chief public health and science officer for Merck Vaccines assumes new role Sept. 8 Read More »